Published in Osteoporos Int on January 01, 1999
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74
Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72
Epidemiology of hip fracture: Worldwide geographic variation. Indian J Orthop (2011) 2.60
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int (2006) 2.34
Pitfalls in the external validation of FRAX. Osteoporos Int (2011) 2.21
Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial. J Gen Intern Med (2014) 2.20
Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int (2004) 2.11
Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res (2008) 2.07
Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int (2007) 1.86
Osteoporosis in men. Endocr Rev (2008) 1.80
Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy. Osteoporos Int (2006) 1.52
Baseline age and time to major fracture in younger postmenopausal women. Menopause (2015) 1.49
Acute traumatic injuries in rural populations. Am J Public Health (2004) 1.43
Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int (2004) 1.43
The burden of hospitalised fractures in Sweden. Osteoporos Int (2004) 1.41
Updated fracture incidence rates for the US version of FRAX. Osteoporos Int (2009) 1.40
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int (2006) 1.36
The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int (2005) 1.35
Fracture rates lower in rural than urban communities: the Geelong Osteoporosis Study. J Epidemiol Community Health (2002) 1.34
Cost-equivalence of different osteoporotic fractures. Osteoporos Int (2003) 1.33
Incidence of hip fractures in Korea. J Bone Miner Metab (2008) 1.30
Incidence and characteristics of distal radius fractures in a southern Swedish region. BMC Musculoskelet Disord (2007) 1.26
Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis (2011) 1.23
Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age: a population-based study. Osteoporos Int (2005) 1.23
Fractures after antiretroviral initiation. AIDS (2012) 1.21
Mortality after distal femur fractures in elderly patients. Clin Orthop Relat Res (2010) 1.20
A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother (2010) 1.20
Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int (2003) 1.19
Fracture risk following bariatric surgery: a population-based study. Osteoporos Int (2013) 1.13
A guide to improving the care of patients with fragility fractures. Geriatr Orthop Surg Rehabil (2011) 1.12
The effects of a FRAX revision for the USA. Osteoporos Int (2009) 1.12
Fracture mechanisms and fracture pattern in men and women aged 50 years and older: a study of a 12-year population-based injury register, Umeå, Sweden. Osteoporos Int (2008) 1.11
Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health (2012) 1.11
Epidemiology of hip fracture in Iran: results from the Iranian Multicenter Study on Accidental Injuries. Osteoporos Int (2006) 1.11
Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA. Osteoporos Int (2016) 1.09
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int (2004) 1.09
Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos Int (2012) 1.08
The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system. J Bone Miner Res (2014) 1.08
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 1.07
Association of hip strength estimates by finite-element analysis with fractures in women and men. J Bone Miner Res (2011) 1.07
Bone health in healthy Indian population aged 50 years and above. Osteoporos Int (2011) 1.05
Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989-2008. Osteoporos Int (2013) 1.05
Fracture risk in women with breast cancer: a population-based study. J Bone Miner Res (2012) 1.03
A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag (2014) 1.02
Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res (2014) 1.01
Fracture risk in men with prostate cancer: a population-based study. J Bone Miner Res (2011) 1.00
What accounts for rib fractures in older adults? J Osteoporos (2011) 1.00
The Elders Risk Assessment Index, an electronic administrative database-derived frailty index, can identify risk of hip fracture in a cohort of community-dwelling adults. Mayo Clin Proc (2012) 1.00
Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients. Osteoporos Int (2010) 0.99
Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial. Am J Clin Nutr (2009) 0.98
Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharm Res (2006) 0.97
An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials. Osteoporos Int (2006) 0.96
Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight. Osteoporos Int (2012) 0.96
Association between myocardial infarction and fractures: an emerging phenomenon. Circulation (2011) 0.96
Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy. Osteoporos Int (2005) 0.95
Interstate variation in the burden of fragility fractures. J Bone Miner Res (2009) 0.95
Trends in subtrochanteric, diaphyseal, and distal femur fractures, 1984-2007. Osteoporos Int (2011) 0.94
Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities. Womens Health Issues (2006) 0.92
Effect of vertebral fractures on function, quality of life and hospitalisation the AGES-Reykjavik study. Age Ageing (2012) 0.90
Epidemiology of osteoporotic hip fractures in Spain. Int Orthop (2005) 0.89
Urban-rural differences in distal forearm fractures: Cohort Norway. Osteoporos Int (2007) 0.89
A distal forearm fracture in childhood is associated with an increased risk for future fragility fractures in adult men, but not women. J Bone Miner Res (2013) 0.88
Secular decreases in fracture rates 1986-2006 for Manitoba, Canada: a population-based analysis. Osteoporos Int (2010) 0.88
Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporos Int (2010) 0.87
Volumetric bone mineral density and bone size in sleep-deprived individuals. Osteoporos Int (2006) 0.86
The economics of improving medication adherence in osteoporosis: validation and application of a simulation model. J Clin Endocrinol Metab (2011) 0.86
Osteoporotic fractures and heart failure in the community. Am J Med (2011) 0.85
Pharmacological treatment of hip fractured patients in Italy: a simulation based on Tuscany regional database for the TARGET project. Clin Cases Miner Bone Metab (2010) 0.85
Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study. J Rheumatol (2013) 0.84
Bone mineral density and incidence of hip fracture in Swedish urban and rural women 1987-2002. Acta Orthop (2010) 0.84
Single-centre study of hip fractures in Prague, Czech Republic, 1997-2007. Int Orthop (2010) 0.83
Incidence of fractures requiring inpatient care. Acta Orthop (2014) 0.83
Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures. Osteoporos Int (2003) 0.83
Second fractures among older adults in the year following hip, shoulder, or wrist fracture. Osteoporos Int (2016) 0.83
An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures. J Bone Miner Res (2013) 0.82
Use of renal function measurements for assessing fracture risk in postmenopausal women. Mayo Clin Proc (2008) 0.82
Age-related changes in the fracture resistance of male Fischer F344 rat bone. Bone (2015) 0.81
Fracture incidence in a large cohort of men age 30 years and older with osteoporosis. Osteoporos Int (2015) 0.80
Spatial and temporal fracture pattern in breast and gynecologic cancer survivors. J Cancer (2015) 0.80
Rural vs. non-rural differences and longitudinal bone changes by DXA and pQCT in men aged 20-66 years: A population-based study. Bone (2015) 0.79
Pharmaco-economic issues in the treatment of severe osteoporosis. Clin Cases Miner Bone Metab (2010) 0.79
Smoking status as a predictor of hip fracture risk in postmenopausal women of northwest Texas. Prev Chronic Dis (2007) 0.79
Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int (2017) 0.78
Long-term fracture risk following adult-onset asthma: a population-based study. Osteoporos Int (2004) 0.78
Predictors of excess mortality after fracture: a population-based cohort study. J Bone Miner Res (2014) 0.78
Potential Extensions of the US FRAX Algorithm. J Osteoporos (2012) 0.78
Fracture risk assessment in Latin America: is Frax an adaptable instrument for the region? Clin Rheumatol (2010) 0.78
Association between household size, residential area, and osteoporosis: analysis of 2008 to 2011 Korea National Health and Nutrition Examination Survey. Korean J Intern Med (2016) 0.78
Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis: a custom strategy for preventing proximal humerus fractures. Rheumatol Int (2015) 0.78
The health benefits of vitamin K. Open Heart (2015) 0.77
Development and validation of a disease model for postmenopausal osteoporosis. Osteoporos Int (2010) 0.77
Reporting of lifetime fractures: methodological considerations and results from the Thai Cohort Study. BMJ Open (2012) 0.77
Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? Osteoporos Int (2009) 0.77
Increased risk of bone fracture among patients with urinary calculi: a nationwide longitudinal population-based study. Osteoporos Int (2014) 0.76
Osteoporosis Imaging in the Geriatric Patient. Curr Radiol Rep (2016) 0.75
Surgery for Type B Ankle Fracture Treatment: a Combined Randomised and Observational Study (CROSSBAT). BMJ Open (2017) 0.75
Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States. Osteoporos Int (2016) 0.75
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49
A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22
Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63
The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol (2000) 3.62
Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology (1988) 3.40
Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27
Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19
Causes of death in patients with tuberous sclerosis. Mayo Clin Proc (1991) 3.18
Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum (1999) 2.98
Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood (1992) 2.81
Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80
Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med (1986) 2.80
Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79
Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77
Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation (1999) 2.71
Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol (2000) 2.68
Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial. Mayo Clin Proc (2001) 2.61
Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59
Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56
The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum (1999) 2.50
Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis (2007) 2.46
Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43
Emotional responses of athletes to injury. Mayo Clin Proc (1990) 2.43
Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA (1993) 2.42
Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc (1981) 2.41
Secular trends in the incidence of hip fractures. Calcif Tissue Int (1987) 2.40
Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res (1990) 2.39
50-year trends in the incidence of anorexia nervosa in Rochester, Minn.: a population-based study. Am J Psychiatry (1991) 2.38
Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res (1999) 2.37
Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35
Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis (2003) 2.34
Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis. J Rheumatol (1999) 2.34
The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med (1995) 2.27
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17
Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984) Neurology (1996) 2.16
Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol (1999) 2.07
The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg (1988) 2.06
Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics (1968) 2.06
Complications leading to surgery after breast implantation. N Engl J Med (1997) 2.05
Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med (1995) 2.02
Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension. Mayo Clin Proc (1991) 2.02
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Epidemiology of sarcopenia. J Am Geriatr Soc (2000) 1.97
Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab (2002) 1.96
Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res (1998) 1.93
Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology (1998) 1.92
The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol (1997) 1.91
Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol (1997) 1.91
Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol (1993) 1.91
Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc (1994) 1.89
Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study. Arthritis Rheum (1997) 1.88
Competitive athletes: preinjury and postinjury mood state and self-esteem. Mayo Clin Proc (1993) 1.87
The declining incidence of stroke. N Engl J Med (1979) 1.86
The epidemiology of venous thromboembolism in the community. Thromb Haemost (2001) 1.86
Trends in right and left-sided colon cancer. Dis Colon Rectum (1983) 1.84
Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol (1994) 1.84
Comorbidity in arthritis. J Rheumatol (1999) 1.83
Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol (2001) 1.78
Utilization of acute care services in the year before and after first stroke: A population-based study. Neurology (1996) 1.77
Bone density and fracture risk in men. J Bone Miner Res (1998) 1.77
The poor prognosis of ruptured intracranial aneurysms of the posterior circulation. J Neurosurg (1995) 1.74
Recurrent spontaneous cervical-artery dissection. N Engl J Med (1994) 1.73
Dose response studies in cotton textile workers. J Occup Med (1973) 1.73
Prevalence and incidence of vertebral deformities. Osteoporos Int (1993) 1.72
Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc (1990) 1.69
Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int (1998) 1.69
Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res (1995) 1.69
A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology (1990) 1.66
The unchanging pattern of subarachnoid hemorrhage in a community. Neurology (1980) 1.66
Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood (1996) 1.65